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Saposin B is a small, nonenzymatic glycosphingolipid activator
protein required for the breakdown of cerebroside sulfates (sul-
fatides) within the lysosome. The protein can extract target lipids
from membranes, forming soluble protein-lipid complexes that are
recognized by arylsulfatase A. The crystal structure of human
saposin B reveals an unusual shell-like dimer consisting of a
monolayer of -helices enclosing a large hydrophobic cavity. Al-
though the secondary structure of saposin B is similar to that of the
known monomeric members of the saposin-like superfamily, the
helices are repacked into a different tertiary arrangement to form
the homodimer. A comparison of the two forms of the saposin B
dimer suggests that extraction of target lipids from membranes
involves a conformational change that facilitates access to the
inner cavity.
The saposins are a group of four structurally related activatorproteins that function in conjunction with hydrolase enzymes
for the stepwise breakdown of glycosphingolipids within the
lysosome (1, 2). These proteins act by modifying the local
environment of target lipids, and ‘‘activate’’ the breakdown of
their substrates by presenting them in a form in which the lipid
scissile bonds are accessible to the active sites of the specific
enzymes. Presumably, the hydrolases cannot form a catalytic
complex with the glycosphingolipids when these are in unmod-
ified membrane bilayers.
Each of the four saposins activates one or more lipid exohy-
drolases. For example, saposin B (also known as the cerebroside
sulfate activator, or CS-Act) facilitates the hydrolysis of the
sulfate group from cerebroside sulfate by arylsulfatase A, re-
sulting in the formation of galactosylceramide (3). This glyco-
lipid is then catabolized to ceramide by -galactosylceramidase
in a reaction activated by saposin C. There seems to be more than
one mechanism of activation by the saposins, and this may
further depend on the particular target lipid. Thus, saposin B is
able to extract and solubilize cerebroside sulfates from mem-
branes, allowing arylsulfatase A to act on the small, diffusible
protein-lipid complexes. Saposin B may also have a physiological
role in activating the hydrolysis of the ganglioside GM1 to GM2
by lysosomal -galactosidase, and in this case, the activator may
act by modifying the local lipid structure at the membrane
surface to allow catalysis to proceed (4).
The saposins belong to a large and diverse family of small,
cysteine-rich proteins that share a common ability to interact
with membranes but act in a wide variety of functions. Other
members of the ‘‘saposin-like’’ superfamily of proteins include
the lung surfactant-associated protein B (SP-B), the tumorolytic
protein NK-lysin, granulysin, the pore-forming amoebapores,
and the membrane-targeting domain of some enzymes (5, 6).
The saposin-like proteins are 80 residues in length and have a
characteristic pattern of conserved cysteines (Fig. 1A; refs. 7 and
8). To date, the three-dimensional modeling of the saposins and
other members of the saposin-like family (9–11) has relied on the
NMR structure of the monomeric NK-lysin, which is a relatively
compact monomer made up from five -helices (12). This fold
has also been seen in the vacuolar-targeting domain of pro-
phytepsin (13) and the antimicrobial peptide bacteriocin AS-48
(14); however, these three structures provide little insight as to
how the small saposin B dimer can solubilize relatively large lipid
ligands. Here, in the 2.2-Å crystal structure of saposin B, we find
conserved secondary structure with the previously determined
monomeric structures but striking differences at the tertiary and
quaternary level. The unexpected dimer structure has important
implications for the understanding of the mechanism of lipid
binding in this family of proteins and illustrates a hitherto
unknown mechanism of adaptation of function within a fold
superfamily.
Methods
Expression and Crystallization. The expression, purification, and
crystallization of the selenomethionine-substituted protein has
been described (15). Briefly, human saposin B was expressed in
Escherichia coli strain AD494(DE3) and purified with heat
treatment, followed by anion exchange, size-exclusion, and hy-
drophobic interaction chromatographies. Crystals belonging to
space group P3121 with unit cell dimensions of a  72.14 Å and
c  94.37 Å were grown by vapor diffusion by mixing equal
amounts of protein solution and reservoir buffer (16% polyeth-
ylene glycol 33500.2 M magnesium acetate0.1 M sodium
cacodylate, pH 5.8) and equilibrating against 1.0 ml of reservoir
solution. The I46C and M10C mutants were generated with the
QuikChange site-directed mutagenesis kit (Stratagene), and
protein purification was carried out as with the native protein.
MS was carried out as described (15).
Crystallographic Data Collection and Structure Determination. All
diffraction data were collected at 100 K. Because of evidence of
partial selenium oxidation during expression and crystallization,
crystals were soaked for 30 sec in a cryoprotectant solution of
mother liquor containing 15% glycerol and 0.1% H2O2 in an
attempt to convert all of the selenium atoms to a uniform
oxidization state (16). Multiwavelength anomalous diffraction
(MAD) data were collected at two wavelengths (1  0.9789 Å,
2  0.9793 Å) at beamline F2 at Cornell High Energy Syn-
chrotron Source (CHESS), Cornell University, but a third
dataset at an energy remote from the Se absorption edge could
not be collected because of the formation of ice on the crystal
surface. Data processing and reduction were done with MOSFLM
and SCALA (17). A partial selenium substructure was deter-
mined with SnB (18) and refined with SHARP (www.globalphasing.
com), producing a phase set with a figure of merit of 0.595 on
acentric reflections. Density modification with DM (17) resulted in
an interpretable map, and an atomic model was traced with the
Abbreviations: PE, phosphatidylethanolamine; rmsd, rms deviation; MSMS, tandem MS.
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program O (19). Refinement and addition of water molecules and
ligands were done with the program package CNS (20). The final
model has 96.3% of the residues in the most favored regions of the
Ramachandran plot. The crystallographic statistics are presented in
Table 1. Molecular graphics were prepared withMOLSCRIPT (21)
and PYMOL (www.pymol.org).
Table 1. Data collection and refinement statistics
Data collection
Wavelength, Å 0.9789 0.9793
Resolution, Å 37–2.2 37–2.2
Unique reflections 14,653 14,644
Redundancy 17.1 10.5
Completeness, % (all data) 98.3 (98.3)* 98.3 (98.3)
Completeness, % (data with I(I)  3) 84.2 (49.6) 80.3 (41.0)
I(I) 8.5 (2.5) 9.0 (2.6)
Rmerge, % 6.5 (29.3) 5.9 (28.9)
Refinement
Resolution, Å 20–2.2
Number of reflections (F(F)  0) 14,613
Rcryst, % 22.2 (23.5)
Rfree,5%, % 26.2 (29.1)
rmsd bonds, Å 0.0077
rmsd angles, ° 1.20




*All values in parentheses are for the high-resolution shell (2.20–2.34 Å).
Fig. 1. (A) Multiple alignment of representative saposin-like proteins from eight different functional families (6). Sequence numbering is according to saposin
B. The sequence alignment was generated with CLUSTALW and includes manual adjustments. Identical amino acids are shaded black; conserved positions are
shaded yellow. Experimentally determined N-glycosylation sites are indicated with red lettering. Human saposin B (SapB) is aligned with human saposins A, C,
and D (SapA, SapC, and SapD), acyloxyacyl hydrolase (AOAH), plant phytepsin (PHY), acid sphingomyelinase (ASM), granulysin (NKG5), pore-forming
amoebapore A (AP-A), Countinin (Count), surfactant-associated protein B (SP-B), and porcine NK-lysin (NKL). Leading and trailing dots indicate cases where the
saposin motif is a sub-sequence of a larger protein. Note that in the phytepsin ‘‘swaposin’’ domain, the sequence block VVSQ. . . TFDG precedes the block
ADPM. . . NRLP, as marked by the red asterisk (32). The secondary structures of saposin B chain A (Top) and NK-lysin (Bottom) are shown as cylinders representing
helices, and the cysteines that are linked by disulfide bonds are connected with brackets. A turn of 310 helix at the end of helix 2 in saposin B is indicated by
hatching. The saposin B residues are assigned to the following environment classes: residues contributing 20 Å2 to the dimer interface (circles); residues facing
the inner cavity but not part of the dimer interface (squares); residues with side chains lining the inner hydrophobic cavity (black symbols); residues with side
chain lining the opening to the cavity (white symbols). The inner cavity is formed only in the AB dimer. (B–D) Ribbon diagrams of chains A and B of saposin B
and of the NK-lysin monomer, respectively. The side chains from chain A that are exposed to the inner cavity are indicated in stick representation.









































Activity Assay. Measurements of the activation of cerebroside
sulfate hydrolysis by saposin B were carried out as described (22)
with two exceptions: (i) [14C]stearic-1 cerebroside sulfate (Amer-
ican Radiolabeled Chemicals, St. Louis) was used in place of the
rat brain [35S]cerebroside sulfate; and (ii) the final determination
of activity was based on the amount of [14C]galactosylceramide
in the organic phase rather than the inorganic sulfate in the
aqueous phase. Briefly, 10 g of [14C]cerebroside sulfate (1,000
cpmg) were added to a solution containing 2.5 units of
arylsulfatase A and varying amounts of saposin B, and the
reaction mixtures were incubated at 37°C for 2 h. The lipids were
extracted, separated by thin layer chromatography, and quanti-
tated by liquid scintillation counting of the scraped bands.
Results and Discussion
Conformational Differences Between Monomers. The crystallo-
graphic asymmetric unit contains three independent peptide
chains (referred to as chains A, B, and C) that form two distinct
homodimers. The first dimer is formed by chains A and B (dimer
AB) and has a pronounced asymmetry. The second dimer (dimer
CC) is formed by chain C and a mate related by a crystallo-
graphic twofold axis and is thus symmetric. Each chain consists
of four amphipathic -helices arranged in a long hairpin that is
bent into a simple V-shape (Fig. 1 B and C). The convex outer
surface of the monomer is hydrophilic, whereas the concave
inner surface of the ‘‘V’’ is lined with the side chains from
hydrophobic residues. As with other members of the saposin-like
family, the fold is stabilized by two disulfide bridges connecting
1 and 4 near the N and C termini of the chains and by one
bridge between 2 and 3 near the hairpin turn. As a result, there
are tight pairwise -helical interactions over the length of the
monomer.
Chains A and C are structurally similar and superimpose with
an rms deviation (rmsd) of 0.90 Å over the C atoms of residues
2–78. However, chain B is bent into a significantly sharper ‘‘V,’’
and can be reasonably superimposed with chains A and C at
either the base (residues 2–20 and 56–78, rmsd  1.0 Å) or
hairpin (residues 26–54 rmsd  1.2 Å) regions. The key struc-
tural differences in the B chain relative to the A and C chains are
(i) a reorganization of the first loop and partial unfolding at the
start of helix 2, and (ii) a highly localized kink in 3 at residue
Tyr-54 (,   100.4°, 10.2°). In chains A and C, helix 3 is
only slightly curved and does not have the sharp kink that is
obvious in the B chain.
Comparison with NK-Lysin. NK-lysin (12) and the other saposin-
like proteins (13, 14) show a similar overall fold consisting of five
amphipathic -helices wound into a closed monomer with a
small hydrophobic core. A comparison of the saposin B chains
with the NK-lysin structure reveals similarities in the secondary
structure and in the lateral interactions between the disulfide-
bonded helices, but the more open saposin B monomer confor-
mation leads to a significantly different tertiary organization
(Fig. 1). Remarkably, the differences are largely caused by
structural changes at the same two points of variability that occur
within the set of saposin B chains, except that they are more
pronounced. First, a sharper turn in loop 1 of NK-lysin results in
direct contacts between helices 1 and 2. Second, the sharp
break between NK-lysin helices 3 and 4 places these two
helices at roughly right angles to each other. This kink in
NK-lysin occurs at Phe-52 (,   140°, 40°) and corresponds
directly to the smaller kink in the 3 helix of chain B of saposin
B. The same break in the equivalent helix is also seen in the
saposin-like insert of prophytepsin (13). In the monomeric
saposin-like proteins, these two features result in direct contacts
between the hairpin and base region of the chains, generating a
closed monomer that buries the core residues and precludes the
saposin B-type dimerization (see below).
Dimer Structure. Saposin B dimers are formed by clasping to-
gether two V-shaped monomers. In the AB dimer, the two chains
interlock to form a shell-like monolayer of -helices, with a long
and extended horseshoe-shaped interface that buries 1,260 Å2
of surface area, or 22% of the monomer surfaces. However, most
of the hydrophobic residues that line the concave surface of the
monomers remain exposed to a large interior cavity, and the
protein does not have a packed hydrophobic core (Fig. 2).
The volume of the internal cavity is 900 Å3, and as a result of
the asymmetry in this dimer, there is a single 13 	 6 Å opening
to the cavity at the subunit interface. It has long been suspected
that the hydrophobic pocket of saposin-B is formed at the dimer
interface (23).
Bound Phospholipid. During the refinement of the structure,
difference electron density maps revealed regions of elongated
Fig. 2. The saposin dimer encloses a large hydrophobic cavity. (A) Stereo
view of the AB dimer. The C trace of the A chain is in light blue, and the B
chain is in dark blue. Residues from the B chain are labeled with primes. The
surface of the inner cavity is in gray mesh, and the positive Fo-Fc density
calculated before the inclusion of the ligand is indicated in dark blue mesh
(contoured at 1.5 ). The final refined phosphatidylethanolamine fragment is
in stick representation. (B and C) Ribbon and solvent-accessible surface dia-
grams of the AB dimer, with coloring as in A. The lipid headgroup is exposed
to solvent, and the acyl chains are contained within the cavity. Disulfide bonds
are indicated with thin yellow lines. (D and E) Ribbon and surface represen-
tations of the symmetric CC dimer with the chains in pink and red. There are
tight interchain contacts at the base, but no contacts between the hairpin
regions and no ordered ligands within the solvent-exposed core.


































electron density within the AB dimer, which we have modeled
as a partially ordered phospholipid (Fig. 2 A). Support for the
presence of copurifying lipid in our saposin B preparations
was obtained from electrospray ionization MS. In a water
acetonitrileformic acid solvent, positive ions were observed at
mz values of 744.8, 718.8, 716.8, 690.5, and 662.5. These values
were within 0.01% of the expected masses for singly protonated
forms of phosphatidylethanolamine (PE) with C18:1C18:1,
C18:0C16:1, C18:1C16:1, C16:0C16:1, and C14:0C16:1 acyl
chains, respectively. A selection from these ions was analyzed
further by tandem MS (MSMS) at a variety of collision gas
concentrations, and in all cases, the expected fragmentation
pattern for the assigned phospholipids was observed (24). Ad-
ditional confirmation was obtained by MSMS on negative ions
measured in a wateracetonitriletriethylamine solvent. The
copurification of E. coli phospholipids has been seen with other
heterologously expressed lipid-binding proteins (25, 26).
Based on the MS results, we have modeled a partially ordered
fragment of PE into the difference electron density with the lipid
headgroup exposed at the opening to the cavity and the two acyl
chains sequestered within the cavity (Fig. 2 A). We see evidence
for additional lipid conformers in both the headgroup and the
acyl chain regions, but we have not modeled this disorder.
Because of the uncertainties in the specific features of the lipid
conformation, the current data does not justify a detailed
analysis of the protein–lipid interactions in this complex. Addi-
tional electron density is also seen deeper within the encapsu-
lated interior, but these features cannot be modeled with con-
fidence. Saposin B is known to have broad capabilities for lipid
solubilization (3, 27). Although a phospholipid is not the target
substrate for the activation reaction, PE and cerebroside sulfate
have similar relative binding affinities in vitro (27), and because
both lipids are present in lysosomal membranes, it is likely that
complexes of saposin B with PE occur in vivo.
Intersubunit Contacts. The dimerization surface can be subdivided
into contacts between the base regions and contacts between the
hairpins (Fig. 3). At the base, there is a tight anti-parallel
coiled-coil interaction between the two N-terminal helices and
a close packing of each C terminus with helix 2 of the opposite
monomer. In the CC dimer, these are essentially the only
interchain contacts, and they result in the burial of 773 Å2 of
surface area. A second set of interactions occurs in the AB dimer
between the hairpin turn of chain B to helix 3 of the A chain.
These contacts bury an additional 486 Å2 of surface area, and
because this surface is continuous with the interface at the base
region, this seals off much of the interior cavity.
The asymmetry in the AB dimer results in significant
differences in the interresidue contacts across the two chains.
The pairs of tyrosines at positions 50 and 54 are aligned on one
face of helix 3. In chain B, these residues participate in the
pore opening on one side of the dimer, whereas in the A chain,
they form part of the closed surface at the ‘‘back’’ of the cavity.
His-31 from the opposite chain seals the back of the cavity by
forming a hydrogen bond with the phenolic oxygen of Tyr-54,
and the close approach of these three aromatic residues is
Fig. 3. (A) Surface burial in the dimer for each of the residues in the three crystallographically independent chains. The open ‘‘front’’ (B) and sealed ‘‘back’’
(C) of the AB dimer are shown. The lipid headgroup protrudes from the opening to the cavity in the front, whereas contacts among His-31(B), Y50(A), and Y54(A)
seal the cavity on the back. (D) The relative orientations of residues H31(C), Y50(C), and Y54(C) (and the equivalent residues related by the twofold symmetry,
not shown in this view) in the CC dimer are similar to those found near the opening to the AB dimer.









































made possible by the tilting in of the hairpin region of chain
B. The opening of the cavity is mostly lined with hydrophobic
residues (Fig. 1A), with the exception of Tyr-50 and Tyr-54
from chain B and Arg-38 of chain A. This arginine may play
a role in the binding of the sulfate group of cerebroside sulfate,
but in general, the structural basis for lipid recognition and
specificity of the activation reaction by saposin B remains
unclear.
The CC dimer is significantly more open and there are no
interchain contacts between the hairpins. The hydrophobic
cavity is, therefore, more exposed to the bulk solvent in this
dimer, and the relative orientation of residues H31, Y50, and
Y54 are similar to those seen on the pore opening side of the AB
complex. Very weak residual electron density is observed within
the cavity of the CC dimer, and we refer to this dimer as the
open or unliganded dimer.
Dimer Flexibility Is Important for Function. To verify the functional
relevance of the dimer and the observed conformational differ-
ences between the AB and CC dimers, we introduced single
cysteine residues at positions near the molecular twofold axis for
the formation of interchain disulfide bonds (Fig. 4). Mutant
M10C is at the base of the dimer in a region where there is little
difference between the two dimers (C-C distances  5.1 and
5.3 Å in AB and CC, respectively), whereas mutation I46C is
near the hairpin turn where the differences are much larger
(C-C distances  6.3 and 15.6 Å in AB and CC, respectively).
The formation of DTT-reducible dimers was confirmed by
SDSPAGE (Fig. 4B) and by MS (data not shown). The wild-
type and both mutant proteins were competent for cerebroside
sulfate binding, as measured by isoelectric focusing and fluo-
rescence spectroscopy after incubation of the protein with lipid
for 24 h at 37°C (data not shown). However, the rate of
stimulation of the cerebroside sulfate hydrolysis reaction by
arylsulfatase A was severely compromised in the I46C mutant
but not in the M10C mutant (Fig. 4C). Thus, a monomeric
species is not required for the function of saposin B, because an
obligate dimer (M10C) is able to function as an activator.
However, f lexibility in the hairpin region is important for the
activity (I46C), and we suggest that structural changes in the
hairpin region are important in the process of extracting lipids
from the membranes. Because the I46C crosslinked saposin B is
competent for sulfatide binding and retains a small but measur-
able level of activity, we propose that this form of the protein
uses other less kinetically favored routes for the formation of the
lipid complexes.
Flexibility at the opening to a hydrophobic cavity is a feature
that is suspected to be important for the recognition and
extraction of lipids from membranes in many other lipid-
transport proteins (26, 28–30). In particular, the GM2 activator
protein (GM2-AP) is functionally related to the saposins and
activates the hydrolysis of the ganglioside GM2 to GM3 by
-hexosaminidase A. However, this activator is a 22-kDa mono-
mer that adopts a -cup topology that has no structural similarity
to saposin B (26). At a global level, however, the GM2-AP is
related to the saposin-B dimer in that it has similar overall
dimensions and contains a large accessible hydrophobic cavity
with an opening lined with a flexible loop. Despite the fact that
saposin B is an all -helical homodimer and that GM2-AP is a
monomer consisting mainly of -structure, saposin B and
GM2-AP may share a similar molecular mechanism for glyco-
sphingolipid activation, as supported by the crosslinking data
presented above.
Insights into Mechanism. The existence of the large hydrophobic
cavity, the encapsulated phospholipid, and the conformational
variability seen between the chains all support a lipid solubili-
zation mechanism for saposin B. These features are consistent
with the observation that saposin B can act as a lipid-transport
protein (31). We propose that the open form of the saposin B
dimer (or conformers similar to it) can interact directly with
membrane surfaces, and promote a reorganization of the lipid
alkyl chains by virtue of the partly accessible hydrophobic
Fig. 4. (A) Superposition of the AB and CC dimers, shown in tube repre-
sentation. Chains A (light blue) and C (pink) superimpose well, as do the base
of chains B (dark blue) and C (red). The kink in the third helix of chain B is
evident in the overlay with the C chain. Residues Met-10 (base) and Ile-46
(hairpin) are near the molecular (pseudo)-symmetry axes and are indicated in
black. Equivalent residues in the dimers are connected by black lines.
(B) SDSPAGE of reduced and nonreduced saposin B with and without the
additional cysteines. Wild-type saposin B is in lanes 1 and 4, the M10C mutant
is in lanes 2 and 5, and I46C is in lanes 3 and 6. DTT was added to lanes 1–3 only.
(C) Activation of cerebroside sulfate hydrolysis by arylsulfatase A in the
presence of wild-type recombinant saposin B (squares), M10C (circles), and
I46C (triangles) crosslinked dimers. Less than 2% hydrolysis of the input
sulfatide was observed in the absence of activator under the assay conditions.


































surfaces of the dimer. With some lipids, and perhaps with some
of the saposins, these stable structures at the membrane surface
may suffice to activate hydrolysis reactions. In the case of cerebro-
side sulfate, saposin B can effect the full extraction of the lipid, and
we propose that this step involves the conformational changes that
we have seen at the two hinge points in the B chain of the AB dimer.
The high exposure of the cerebroside sulfate headgroup in a soluble
saposin B-lipid complex would allow for the formation of a pro-
ductive enzyme-substrate complex with arylsulfatase A.
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